In light of the significant drop in Regeneron’s stock price, a natural question emerges: is REGN now a viable buying ...

Aflibercept 2 mg (Eylea, Bayer AG) injections were administered using a prefilled syringe (PFS), following the manufacturer’s indications, with a 30-gauge needle and injecting 0.05 mL of medication (2 ...

The Seoul Central District Court ruled against Regeneron, which had sought to block Samsung Bioepis from producing and selling a biosimilar referencing the US firm’s Eylea, a blockbuster medicine used ...

Regeneron acquired 23andMe for $256M, gaining 15M DNA profiles to enhance R&D. Find out why REGN stock is a Buy.

A case analysis provides a new understanding of the ocular side effects of Blenrep, an antibody drug conjugate that is being ...

Peterborough Litter Wombles said it was the second time the group had found an "unusual" amount of needles A city litter-picking group said 105 discarded drug syringes were discovered by ...

The potential acquirer has 11 FDA-approved drugs, including Dupixent and Eylea. 23andMe gene privacy question takes a turn in bankruptcy Why a big AI player wants a quarter-million bucks from ...

It also makes Eylea, which it developed with Bayer. Ahead of Monday's moves, Regeneron's stock has fallen 16.6% in 2025, while the S&P 500 SPX has risen 1.3%. Also read: Regeneron's earnings ...

Kriya Therapeutics recently announced preclinical data on its gene therapy candidate KRIYA-825, a one-time gene therapy delivered by suprachoroidal injection, for the treatment of geographic atrophy ...

The global retractable needle safety syringes market is poised for significant expansion over the next decade, fueled by a growing emphasis on the safety of healthcare professionals and patients alike ...

The deal with ADARx expands AbbVie’s siRNA focus. Image credit: hapabapa / iStock Editorial via Getty Images. AbbVie has signed a collaboration and licensing agreement with US-based ADARx ...

The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL ...